A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients

ClinicalTrials.gov ID: NCT00876915

Public ClinicalTrials.gov record NCT00876915. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective Randomized Multicenter Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients

Study identification

NCT ID: NCT00876915
Recruitment status: Terminated
Study type: Interventional
Phase: Phase 3
Lead sponsor: University of Rochester; Other
Enrollment: 218 participants

Conditions and interventions

Conditions

Interventions

dalteparin injection Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 30, 2009
Primary completion: Jun 30, 2014
Completion: Nov 30, 2014
Last update posted: Nov 23, 2015

2009 – 2014

United States locations

U.S. sites: 6
U.S. states: 4
U.S. cities: 5

Facility	City	State	ZIP	Site status
University of California, Davis	Sacramento	California	95817	—
Roswell Park Cancer Institute	Buffalo	New York	14263	—
Rochester General Hospital	Rochester	New York	14621	—
University of Rochester Medical Center	Rochester	New York	14642	—
Duke University School of Medicine	Durham	North Carolina	27705	—
Cleveland Clinic	Cleveland	Ohio	44195	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00876915, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Nov 23, 2015 · Synced Jul 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00876915 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →